✦ LIBER ✦

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

✍ Scribed by Tsutomu Yoshida; Toshiyuki Sawa; Takashi Ishiguro; Akane Horiba; Shinya Minatoguchi; Hisayoshi Fujiwara

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 115 KB
Volume: 17
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-008-0508-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combined treatment of CT-guided perc

The combined treatment of CT-guided percutaneous125I seed implantation and chemotherapy for non-small-cell lung cancer

✍ Shengchu Zhang; Yihu Zheng; Panpan Yu; Fuxiang Yu; Qiyu Zhang; Yinxiang Lv; Xiao 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 558 KB

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

Combination chemotherapy with and withou

Combination chemotherapy with and without the methanol-extracted residue of bacillus calmette-guerin (MER) in extensive non-small-cell lung cancer: A prospective randomized study for the piedmont oncology association

✍ Frederick Richards II; Virginia Howard; Anita Shore; Hyman B. Muss; Douglas R. W 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A